Reaktion #1128069

ord-f50733134cdc4147907a59a8d6c7bd14

Reaktionsgleichung

CNC(=O)c1cccc(C)c1Nc1nc(Cl)ncc1Cl
2-(2,5-Dichloro-pyrimidin-4-ylamino)-3,N-dimethyl-benzamide
CC1(C)CCC(=O)Nc2ccc(N)cc21
7-Amino-5,5-dimethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one
CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2
DL-10-Camphorsulfonic acid
CNC(=O)c1cccc(C)c1Nc1nc(Nc2ccc3c(c2)C(C)(C)CCC(=O)N3)ncc1Cl
2-[5-Chloro-2-(5,5-dimethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-3,N-dimethyl-benzamide
Ausbeute 3.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeMicrowaved
  2. 2
    Sonstigereaction at 120° C. for 20 minutes
  3. 3
    SonstigeEvaporated off solvent
  4. 4
    Sonstigepurified with normal phase chromatography

Vorschrift

Combined 2-(2,5-Dichloro-pyrimidin-4-ylamino)-3,N-dimethyl-benzamide (90 mg, 0.289 mmol), 7-Amino-5,5-dimethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one (62 mg, 0.304 mmol), DL-10-Camphorsulfonic acid (84 mg, 0.362 mmol) and isopropanol (3 mL) in a microwave tube. Microwaved reaction at 120° C. for 20 minutes. Evaporated off solvent and purified with normal phase chromatography to yield an off-white solid, 2-[5-Chloro-2-(5,5-dimethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-3,N-dimethyl-benzamide (4.2 mg, 3%). LCMS: m/z=479.37 (M+H+), 1H NMR (400 MHz, CDCl3) δ 8.67 (s, 1H), 8.06 (d, 1H, J=1.3 Hz), 7.39 (m, 4H), 7.27 (m, 1H), 7.18 (s, 1H), 7.14 (s, 1H), 6.66 (d, 1H, J=8.6 Hz), 6.10 (m, 1H), 2.92 (m, 3H), 2.34 (m, 2H), 2.25 (s, 3H), 2.05 (m, 2H), 1.30 (s, 6H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08552186B2uspto-grants-2013_10